In this MedPage Today interview, Rachel Weinerman, MD, a reproductive endocrinologist at Case Western Reserve University and University Hospitals in Cleveland, explains why menopause hormone therapy ...

PARS, developed at the Vanderbilt Center for Patient and Professional Advocacy, includes complaints about care and treatment, communication, concern for patients, accessibility, and payment issues. It ...

Having a token clinician advisor or one person sitting on a committee isn't enough. Real co-creation means embedding ...

LONG BEACH, Calif. -- Depletion of a payment assistance program has translated into worse vision outcomes for older patients ...

Building on bispecific antibodies, four of which have been approved by the FDA to treat relapsed/refractory multiple myeloma, ...

Over 60% of patients who received ervogastat plus clesacostat for 48 weeks achieved MASH resolution without fibrosis ...

During implementation and across age groups, 9.7% of patients were reported to snore, 12.2% had sleep problems, and 34.4% got insufficient sleep. Among infants, 6.5% had reported bed sharing. Among ...

HHS and the Department of Agriculture define moderate drinking as no more than two drinks per day for men and no more than ...

TORONTO -- Biomarkers pointing to increased risk for Alzheimer's disease were markedly reduced with the investigational cholesteryl ester transfer protein (CETP) inhibitor obicetrapib relative to ...

Prescribing information for oseltamivir carries warnings about abnormal behavior in kids with flu based on case reports. Concerns about possible side effects may contribute to oseltamivir being ...